Stepwise Epigenetic and Phenotypic Alterations Poise CD8+ T Cells to Mediate Airway Hyperresponsiveness and Inflammation
Overview
Authors
Affiliations
The functional plasticity of CD8(+) T cells in an atopic environment, encompassing a spectrum from IFN-γ- to IL-13-producing cells, is pivotal in the development of allergic airway hyperresponsiveness and inflammation, and yet remains mechanistically undefined. We demonstrate that CD8(+) T cell IL-13 induction proceeded through a series of distinct IL-4/GATA3-regulated stages characterized by gene expression and epigenetic changes. In vivo, CD8(+) T cells exposed to an environment rich in IL-4 displayed epigenetic changes at the GATA3 and IL-13 promoter indicative of transcriptional activation and IL-13 production. In vitro, IL-4 triggered the stepwise molecular conversion of CD8(+) T cells from IFN-γ to IL-13 production. During the initial stage, IL-4 suppressed T-bet and induced GATA3 expression, characterized by enhanced activating histone modifications and RNA polymerase II (Pol II) recruitment to the GATA3 locus. Notably, recruitment of GATA3 and RNA Pol II to the IL-13 promoter was also detected at this initial stage. However, enhanced IL-13 transcription only occurred at a later stage after TCR stimulation, indicating that IL-4-induced GATA3 recruitment poises the IL-13 locus for TCR-mediated transcription. Thus, both in vivo and in vitro, an atopic (IL-4) environment poises CD8(+) T cells via stepwise epigenetic and phenotypic mechanisms for pathogenic conversion to IL-13 production, which is ultimately triggered via an allergen-mediated TCR stimulus.
Chronic Inflammation in Asthma: Looking Beyond the Th2 Cell.
Olsthoorn S, van Krimpen A, Hendriks R, Stadhouders R Immunol Rev. 2025; 330(1):e70010.
PMID: 40016948 PMC: 11868696. DOI: 10.1111/imr.70010.
Type-2 CD8 T-cell formation relies on interleukin-33 and is linked to asthma exacerbations.
van der Ploeg E, Krabbendam L, Vroman H, van Nimwegen M, de Bruijn M, de Boer G Nat Commun. 2023; 14(1):5137.
PMID: 37612281 PMC: 10447424. DOI: 10.1038/s41467-023-40820-x.
Barcenilla H, Pihl M, Wahlberg J, Ludvigsson J, Casas R Front Immunol. 2022; 12:797172.
PMID: 35095874 PMC: 8791064. DOI: 10.3389/fimmu.2021.797172.
CD8 Tc2 cells: underappreciated contributors to severe asthma.
Hinks T, Hoyle R, Gelfand E Eur Respir Rev. 2019; 28(154).
PMID: 31748421 PMC: 6887553. DOI: 10.1183/16000617.0092-2019.
Ning F, Takeda K, Schedel M, Domenico J, Joetham A, Gelfand E J Allergy Clin Immunol. 2019; 143(6):2026-2037.e7.
PMID: 30660639 PMC: 11098440. DOI: 10.1016/j.jaci.2018.11.049.